Currently, there are 225.53M common shares owned by the public and among those 223.60M shares have been available to trade.
The company’s stock has a 5-day price change of 6.89% and 33.31% over the past three months. MAC shares are trading 35.64% year to date (YTD), with the 12-month market performance up to 89.58% higher. It has a 12-month low price of $10.75 and touched a high of $20.42 over the same period. MAC has an average intraday trading volume of 1.52 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by 8.16%, 12.90%, and 27.88% respectively.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Institutional ownership of Macerich Co (NYSE: MAC) shares accounts for 94.34% of the company’s 225.53M shares outstanding.
It has a market capitalization of $4.93B and a beta (3y monthly) value of 2.54. The earnings-per-share (ttm) stands at -$0.90. The company has a debt-to-equity ratio at 1.74. Price movements for the stock have been influenced by the stock’s volatility, which stands at 2.50% over the week and 3.40% over the month.
Earnings per share for the fiscal year are expected to increase by 122.92%, and -188.64% over the next financial year.
Looking at the support for the MAC, a number of firms have released research notes about the stock. Scotiabank stated their Sector Underperform rating for the stock in a research note on May 17, 2024, with the firm’s price target at $16-$14. Piper Sandler coverage for the Macerich Co (MAC) stock in a research note released on May 01, 2024 offered a Underweight rating with a price target of $11. Citigroup was of a view on March 22, 2024 that the stock is Neutral, while Piper Sandler gave the stock Neutral rating on October 02, 2023, issuing a price target of $11- $12. Goldman on their part issued Sell rating on March 21, 2023.
